Skip to main content
Premium Trial:

Request an Annual Quote

ViaLogy

Premium

ViaLogy of Pasadena, Calif, a spinoff of ViaSpace Technologies, a technology commercialization company developed by the NASA/Caltech Jet Propulsion Laboratory, this week announced the launch of a microarray analysis service targeting large-scale users of microarrays. ViaLogy will launch services based on its quantum resonance interferometry (QRI) technology, a proprietary method that it says can amplify signals previously garbled by background interference.

The company will accept data files from existing microarray instrumentation and databases and reprocess it using its technology in a service available online on a pay-per-use basis, the company said in a statement. The online service will become available in December.

Results should be available within 24 hours, the company said.

The ViaLogy technology, based on concepts gleaned from aerospace research, allows the amplification of signals to enable the detection and quantification of hybridization events that other technologies might not perceive due to background noise.

ViaLogy’s microarray service is pre-calibrated and selectable for several different types of Affymetrix GeneChip technology and the company is adding capabilities for formats on glass slides.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.